View Clinical Trial (Medical Research Study)
A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. - NCT00428220-Heidelberg - 007(Clinical Trial 161213)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials
| City: |
|
Heidelberg |
|
Country:
|
|
Australia |
|
|
|
| Conditions: |
|
Carcinoma, Renal Cell - Breast Neoplasms - Carcinoma, Islet Cell - Gastrointestinal Stromal Tumors |
| Purpose: |
|
This is a study using sunitinib for patients ending treatment on a previous sunitinib malate
protocol to continue to receive sunitinib. The patient must have been enrolled in one of
the following studies: A6181107, A6181108, A6181110, A6181111, or A6181112.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- Must have ended treatment from one of the following sunitinib studies: A6181107,
A6181108, A6181110, A6181111, or A6181112.
Exclusion Criteria:
- See inclusion criteria |
|
|
|
|
|
|
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
January 19, 2010 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|